Seeing it through: Translational validation of new medical imaging modalities

Biomedical Optics Express

Volumn 3, Issue 4, 2012, Pages 764-776

  Aldrich, Melissa B ^a   Marshall, Milton V ^a   Sevick Muraca, Eva M ^a   Lanza, Greg ^b   Kotyk, John ^b   Culver, Joseph ^b   Wang, Lihong V ^b   Uddin, Jashim ^c   Crews, Brenda C ^c   Marnett, Lawrence J ^c   Liao, Joseph C ^d   Contag, Chris ^d   Crawford, James M ^e   Wang, Ken ^f   Reisdorph, Bill ^g   Appelman, Henry ^g   Kim Turgeon, D ^g   eyer, Charles ^g   Wang, Tom ^g  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^f MAYO CLINIC ROCHESTER   (United States)

^g UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEDICAL IMAGING;

CLINICAL USE; IMAGING DEVICE; IMAGING MODALITY; OPTICAL IMAGING; RESEARCH GROUPS; SURGICAL GUIDANCE; TRANSLATIONAL RESEARCH;

RESEARCH;

EID: 84863966250     PISSN: None     EISSN: 21567085     Source Type: Journal    
DOI: 10.1364/BOE.3.000764     Document Type: Article

References (37)

1. L. V. Wang and S. Hu, "Photoacoustic tomography: in vivo imaging from organelles to organs," Science (to be published).
2. C. H. Kim, T. N. Erpelding, L. Jankovic, and L. V. Wang, "Performance benchmarks of an array-based hand-held photoacoustic probe adapted from a clinical ultrasound system for non-invasive sentinel lymph node imaging," Philos. Transact. A Math. Phys. Eng. Sci. 369(1955), 4644-4650 (2011).
3. C. H. Kim, T. N. Erpelding, K. Maslov, L. Jankovic, W. J. Akers, L. Song, S. Achilefu, J. A. Margenthaler, M. D. Pashley, and L. V. Wang, "Handheld array-based photoacoustic probe for guiding needle biopsy of sentinel lymph nodes," J. Biomed. Opt. 15(4), 046010 (2010).
4. C. H. Kim, T. N. Erpelding, L. Jankovic, M. D. Pashley, and L. V. Wang, "Deeply penetrating in vivo photoacoustic imaging using a clinical ultrasound array system," Biomed. Opt. Express 1(1), 278-284 (2010).
5. L. V. Wang, "Multiscale photoacoustic microscopy and computed tomography," Nat. Photonics 3(9), 503-509 (2009).
6. L. V. Wang, "Prospects of photoacoustic tomography," Med. Phys. 35(12), 5758-5767 (2008).
7. X. Wang, Y. Pang, G. Ku, X. Xie, G. Stoica, and L. V. Wang, "Noninvasive laser-induced photoacoustic tomography for structural and functional in vivo imaging of the brain," Nat. Biotechnol. 21(7), 803-806 (2003).
8. J. C. Rasmussen, I.-C. Tan, M. V. Marshall, C. E. Fife, and E. M. Sevick-Muraca, "Lymphatic imaging in humans with near-infrared fluorescence," Curr. Opin. Biotechnol. 20(1), 74-82 (2009).
9. J. C. Rasmussen, I.-C. Tan, M. V. Marshall, K. E. Adams, S. Kwon, C. E. Fife, E. A. Maus, L. A. Smith, K. R. Covington, and E. M. Sevick-Muraca, "Human lymphatic architecture and dynamic transport imaged using near-infrared fluorescence," Transl Oncol 3(6), 362-372 (2010).
10. L. Sampath, S. Kwon, M. A. Hall, R. E. Price, and E. M. Sevick-Muraca, "Detection of cancer metastases with a dual-labeled near-infrared/positron emission tomography imaging agent," Transl Oncol 3(5), 307-317 (2010).
11. M. V. Marshall, D. Draney, E. M. Sevick-Muraca, and D. M. Olive, "Single-dose intravenous toxicity study of IRDye 800CW in Sprague-Dawley rats," Mol. Imaging Biol. 12(6), 583-594 (2010).
12. M. A. Hall, S. Kwon, H. Robinson, P. A. Lachance, A. Azhdarinia, R. Ranganathan, R. E. Price, W. Chan, and E. M. Sevick-Muraca, "Imaging prostate cancer lymph node metastases with a multimodality contrast agent," Prostate 72(2), 129-146 (2012).
13. M. B. Aldrich, X. Wang, A. Hart, S. Kwon, L. Sampath, M. V. Marshall, and E. M. Sevick-Muraca, "Assessment of free dye in solutions of dual-labeled antibody conjugates for in vivo molecular imaging," Mol. Imaging Biol. 13(1), 32-42 (2011).
14. K. E. Adams, J. C. Rasmussen, C. Darne, I. C. Tan, M. B. Aldrich, M. V. Marshall, C. E. Fife, E. A. Maus, L. A. Smith, R. Guilloid, S. Hoy, and E. M. Sevick-Muraca, "Direct evidence of lymphatic function improvement after advanced pneumatic compression device treatment of lymphedema," Biomed. Opt. Express 1(1), 114-125 (2010).
15. A. J. Dannenberg, S. M. Lippman, J. R. Mann, K. Subbaramaiah, and R. N. DuBois, "Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention," J. Clin. Oncol. 23(2), 254-266 (2005).
16. M. M. Bertagnolli, C. J. Eagle, A. G. Zauber, M. Redston, S. D. Solomon, K. Kim, J. Tang, R. B. Rosenstein, J. Wittes, D. Corle, T. M. Hess, G. M. Woloj, F. Boisserie, W. F. Anderson, J. L. Viner, D. Bagheri, J. Burn, D. C. Chung, T. Dewar, T. R. Foley, N. Hoffman, F. Macrae, R. E. Pruitt, J. R. Saltzman, B. Salzberg, T. Sylwestrowicz, G. B. Gordon, and E. T. Hawk, APC Study Investigators, "Celecoxib for the prevention of sporadic colorectal adenomas," N. Engl. J. Med. 355(9), 873-874 (2006).
17. M. J. Edelman, D. Watson, X. Wang, C. Morrison, R. A. Kratzke, S. Jewell, L. Hodgson, A. M. Mauer, A. Gajra, G. A. Masters, M. Bedor, E. E. Vokes, and M. J. Green, "Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203," J. Clin. Oncol. 26(6), 848-855 (2008).
18. A. S. Kalgutkar, B. C. Crews, S. W. Rowlinson, A. B. Marnett, K. R. Kozak, R. P. Remmel, and L. J. Marnett, "Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors," Proc. Natl. Acad. Sci. U.S.A. 97(2), 925-930 (2000).
19. M. J. Uddin, B. C. Crews, A. L. Blobaum, P. J. Kingsley, D. L. Gorden, J. O. McIntyre, L. M. Matrisian, K. Subbaramaiah, A. J. Dannenberg, D. W. Piston, and L. J. Marnett, "Selective visualization of cyclooxygenase-2 in inflammation and cancer by targeted fluorescent imaging agents," Cancer Res. 70(9), 3618-3627 (2010).
20. P.-L. Hsiung, J. Hardy, S. Friedland, R. Soetikno, C. B. Du, A. P. Wu, P. Sahbaie, J. M. Crawford, A. W. Lowe, C. H. Contag, and T. D. Wang, "Detection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopy," Nat. Med. 14(4), 454-458 (2008).
21. T. D. Wang, "Targeted imaging of flat and depressed colonic neoplasms," in Non-Polypoid (Flat and Depressed) Colorectal Neoplasms. Gastrointestinal Endoscopy Clinics of North America, R. M. Soetikno and T. Kaltenbach, eds. (Elsevier Saunders, 2010).
22. M. Goetz and T. D. Wang, "Molecular imaging in gastrointestinal endoscopy," Gastroenterology 138(3), 828-833.e1 (2010).
23. B. P. Joshi and T. D. Wang, "Exogenous molecular probes for targeted imaging in cancer: focus on multi-modal imaging," Cancers 2(2), 1251-1288 (2010).
24. S. J. Miller, B. P. Joshi, Y. Feng, A. Gaustad, E. R. Fearon, and T. D. Wang, "In vivo fluorescence-based endoscopic detection of colon dysplasia in the mouse using a novel peptide probe," PLoS ONE 6(3), e17384 (2011).
25. S. F. Elahi, S. J. Miller, B. Joshi, and T. D. Wang, "Targeted imaging of colorectal dysplasia in living mice with fluorescence microendoscopy," Biomed. Opt. Express 2(4), 981-986 (2011).
26. S. J. Miller, C. M. Lee, B. P. Joshi, A. Gaustad, E. J. Seibel, and T. D. Wang, "Targeted detection of murine colonic dysplasia in vivo with flexible multi-spectral scanning fiber endoscopy," J. Biomed. Opt. (to be published).
27. P. L. Hsiung and T. D. Wang, "In vivo biomarkers for targeting colorectal neoplasms," Cancer Biomark. 4(6), 329-340 (2008).
28. M. Li and T. D. Wang, "Targeted endoscopic imaging," in Enhanced Endoscopic Imaging. Gastrointestinal Endoscopy Clinics of North America, K. Wang and G. Elta, eds. (Elsevier Saunders, 2009).
29. T. D. Wang, University of Michigan, 109 Zina Pitcher Place, Ann Arbor, MI 48109, USA, is preparing a manuscript to be called "Phase 1 study of molecular probes to colonic dysplasia."
30. S. S. Mehta, Commercializing Successful Biomedical Technologies (Cambridge University Press, 2008).
31. S. L. Gibbs-Strauss, M. Rosenberg, B. L. Clough, S. L. Troyan, and J. V. Frangioni, "First-in-human clinical trials of imaging devices: an example from optical imaging," in Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 2009. EMBC 2009 (IEEE, 2009), pp. 2001-2004.
32. S. Gioux, H. S. Choi, and J. V. Frangioni, "Image-guided surgery using invisible near-infrared light: fundamentals of clinical translation," Mol. Imaging 9(5), 237-255 (2010).
33. Network for Translational Research, Handbook for NTR Investigators (Nov. 9, 2010), http://ntroi.wustl.edu/wiki/ntroi/images/d/d7/Handbook_for_NTR_Investigators_110910_for_upload.pdf.
34. F. Wang, P. Hussels, and P. Liu, "Securely and flexibly sharing a biomedical data management system," Proc. SPIE 7264(726402), 1-8 (2009).
35. B. Zhu, I. C. Tan, J. C. Rasmussen, and E. M. Sevick-Muraca, "Validating the sensitivity and performance of near-infrared fluorescence imaging and tomography devices using a novel solid phantom and measurement approach," Technol. Cancer Res. Treat. 11(1), 95-104 (2012).
36. I. C. Tan, E. A. Maus, J. C. Rasmussen, M. V. Marshall, K. E. Adams, C. E. Fife, L. A. Smith, W. Chan, and E. M. Sevick-Muraca, "Assessment of lymphatic contractile function after manual lymphatic drainage using near-infrared fluorescence imaging," Arch. Phys. Med. Rehabil. 92(5), 756-764.e1 (2011).
37. W. A. Wells, P. E. Barker, C. MacAulay, M. Novelli, R. M. Levenson, and J. M. Crawford, "Validation of novel optical imaging technologies: the pathologists' view," J. Biomed. Opt. 12(5), 051801 (2007).